Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models
- 20 April 2020
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 95 (8), 918-926
- https://doi.org/10.1002/ajh.25837
Abstract
Venous thromboembolic events (VTE) are a frequent complication of lymphoma. We conducted a retrospective analysis to compare VTE risk in diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL). Subjects were randomly assigned to training and validation sets to identify risk factors of VTE and evaluate risk model performance, including the Khorana score.790 patients were diagnosed from 2002 to 2014 (DLBCL=542, FL=248). Median follow up was 49 months. We observed 106 VTE, with higher incidence in DLBCL (5‐year cumulative incidence = 16.3% vs. 3.8% in FL patients). Five–year OS for patients with VTE was 51.4% vs. 73.1% in patients without VTE (p <0.0001). Baseline VTE risk factors identified in the training cohort included lymphoma subtype, previous VTE, ECOG performance status ≥2, decreased albumin, increased calcium, elevated WBC, absolute lymphocyte count or monocyte count, and presence of bulky disease. Addition of new variables to the Khorana score improved its performance measured by Akaike information criterion and Concordance index. A new risk model including lymphoma subtype, albumin, WBC count, and bulky disease was validated in time–based ROC analyses. These findings were confirmed in the validation cohort. Lymphoma subtypes have different VTE risk. The effect of lymphoma subtype was independent from disease burden and the use of systemic therapy. The Khorana risk–score was validated in time to event analyses, and a more robust lymphoma–specific VTE risk score is proposed. These findings suggest lymphoma patients with highest VTE risk can be identified with baseline parameters.This publication has 27 references indexed in Scilit:
- Lymphoma and venous thromboembolism: influence on mortalityThrombosis Research, 2014
- Thrombosis and Cancer: Emerging Data for the Practicing OncologistAsco Educational Book, 2013
- Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian populationThrombosis Research, 2012
- Incidence and Risk Factors of Venous Thromboembolic Events in LymphomaThe American Journal of Medicine, 2010
- Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 eventsBlood, 2010
- Follicular Lymphoma in the United States: First Report of the National LymphoCare StudyJournal of Clinical Oncology, 2009
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiologyAnnals of Hematology, 2004
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999